A. L. Maître

发表

Prognostic and Predictive Value of Epidermal Growth Factor Receptor Tyrosine Kinase Domain Mutation Status and Gene Copy Number for Adjuvant Chemotherapy in Non-small Cell Lung Cancer

L. Seymour, D. Gandara, M. Tsao, 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Effect of continuous statistically standardized measures of estrogen and progesterone receptors on disease-free survival in NCIC CTG MA.12 Trial and BC Cohort

M. Ellis, S. Leung, T. Nielsen, 2013, Breast Cancer Research.

Presentation of non-final results of randomized controlled trials (RCTs) at major oncology meetings

D. Cescon, K. Ding, A. L. Maître, 2008 .

Individual patient data-based meta-analysis assessing pre-operative chemotherapy in resectable oesophageal carcinoma

A. L. Maître, S. Michiels, J. Tierney, 2007 .

P1-06-08: Effect of Treatment Emergent Symptoms on Relapse Free Survival: NCIC CTG MA.12 a Randomized Placebo-Controlled Trial of Tamoxifen after Adjuvant Chemotherapy in Pre-Menopausal Women in Early Breast Cancer.

K. Gelmon, A. L. Maître, V. Bramwell, 2011 .

Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis

Brian O'Sullivan, Jacques Bernier, Richard Sylvester, 2006, The Lancet.

Elevated Plasma Ferritin and Busulfan Pharmacodynamics During High‐dose Chemotherapy Regimens in Children with Malignant Solid Tumors

A. L. Maître, A. Paci, G. Vassal, 2007, Clinical pharmacology and therapeutics.

Altered fractionated radiotherapy in head and neck cancer – Authors' reply

J. Pignon, J. Bourhis, A. L. Maître, 2006, The Lancet.

Treatment-Emergent Symptoms and the Risk of Breast Cancer Recurrence in the NCIC CTG MA.27 Adjuvant Aromatase Inhibitor Trial.

M. Ellis, G. Sledge, A. L. Maître, 2009 .

Treatment-associated musculoskeletal and vasomotor symptoms and relapse-free survival in the NCIC CTG MA.27 adjuvant breast cancer aromatase inhibitor trial.

M. Ellis, G. Sledge, A. L. Maître, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A meta-analysis of individual patient data from randomized trials assessing chemotherapy with and without estramustine in patients with castration-refractory prostate cancer.

J. Pignon, A. L. Maître, S. Michiels, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The influence of sex on efficacy, toxicity and delivery of treatment in National Cancer Institute of Canada Clinical Trials Group (NCIC CTG) non-small cell lung cancer (NSCLC) chemotherapy trials

L. Seymour, K. Ding, A. L. Maître, 2008 .

Hyperfractionated or accelerated radiotherapy for head and neck cancer.

K. Ang, J. Horiot, J. Pignon, 2010 .

Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis

K. Ang, J. Horiot, J. Pignon, 2006, The Lancet.